Singapore - English - HSA (Health Sciences Authority)

li ta shen medical trader - aluminium hydroxide (dried gel); liquorice extract; magnesium trisilicate; sodium bicarbonate - tablet - 200 mg - aluminium hydroxide (dried gel) 200 mg; liquorice extract 50 mg; magnesium trisilicate 200 mg; sodium bicarbonate 100 mg

Ireland - English - HPRA (Health Products Regulatory Authority)

pierre fabre medicament - aluminium hydroxide gel, dried magnesium carbonate light alginic acid silica colloidal hydrated - tablets chewable - 30/40/200/ milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

bayer limited - alginic acid; calcium carbonate; magnesium carbonate - chewable tablet - 625/73.5/150 milligram(s) - combinations and complexes of aluminium, calcium and magnesium compounds

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

j m loveridge ltd - magnesium carbonate heavy - not applicable - 1mg/1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - magnesium carbonate heavy - not applicable - 1mg/1mg

United States - English - NLM (National Library of Medicine)

exela pharma sciences, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia. in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

idaman pharma manufacturing sdn bhd - magnesium trisilicate; aluminium hydroxide -

Ireland - English - HPRA (Health Products Regulatory Authority)

j b tillotts limited - deglycyrrhizinized extract of liquorice aluminium hydroxide gel magnesium carbonate sodium bicarbonate - tablets

Ireland - English - HPRA (Health Products Regulatory Authority)

sterling health limited - alginic acid aluminium hydroxide gel, dried sodium bicarbonate magnesium trisilicate - tablets

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - sodium bicarbonate, quantity: 84 mg/ml - injection, solution - excipient ingredients: disodium edetate; water for injections - sodium bicarbonate injection is indicated as an alkalinising agent in the treatment of metabolic acidosis which may occur in many conditions including diabetes, starvation, hepatitis, cardiac arrest, shock, severe dehydration, renal insufficiency, severe diarrhoea, addison's disease or administration of acidifying salts (e.g. excessive sodium chloride, calcium chloride, ammonium chloride). sodium bicarbonate injection is also used to increase urinary ph in order to increase the solubility of certain weak acids (e.g. cystine, sulphonamides, uric acid) and in the treatment of certain intoxications (e.g. methanol, phenobarbitone, salicylates, lithium) to decrease renal absorption of the drug or to correct acidosis.